Conestoga Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RP
RealPage, Inc.
RP
|
+$36.8M |
| 2 |
Q2 Holdings
QTWO
|
+$30.3M |
| 3 |
Mercury Systems
MRCY
|
+$22.9M |
| 4 |
Casella Waste Systems
CWST
|
+$20.6M |
| 5 |
MODN
MODEL N, INC.
MODN
|
+$19.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albany International
AIN
|
+$50.3M |
| 2 |
Blackbaud
BLKB
|
+$40.7M |
| 3 |
Protolabs
PRLB
|
+$21.9M |
| 4 |
Trex
TREX
|
+$19.4M |
| 5 |
Paylocity
PCTY
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.81% |
| 2 | Industrials | 29.02% |
| 3 | Healthcare | 18.03% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Materials | 5.57% |
Similar funds
Conestoga Capital Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Conestoga Capital Advisors held 148 positions worth $4.96B, up 7.9% from $4.59B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Conestoga Capital Advisors deployed $188M of net new capital in Q3 2020, opening 2 new positions and adding to 84 existing holdings. Its largest new stake was Laird Superfood: 50,000 shares worth $2.29M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Protolabs, an estimated $21.9M trimmed.
- Conestoga Capital Advisors's largest Q3 2020 buy was Laird Superfood: 50,000 shares worth $2.29M.
- Conestoga Capital Advisors added most to RealPage, Inc. in Q3 2020, an estimated $36.8M increase.
- Conestoga Capital Advisors's biggest Q3 2020 reduction was Protolabs, cutting an estimated $21.9M.
- Conestoga Capital Advisors fully exited Albany International in Q3 2020, selling an estimated $50.3M.
- Conestoga Capital Advisors's ten largest holdings make up 30% of its $4.96B portfolio in Q3 2020.
- Conestoga Capital Advisors opened 2 new positions and closed 5 in Q3 2020.
- Conestoga Capital Advisors's portfolio value rose 7.9% quarter-over-quarter to $4.96B.
Based on Conestoga Capital Advisors's 13F filing for Q3 2020, filed 23 Oct 2020.